Streamlined Poststroke Treatment Order Sets During the SARS-CoV-2 Pandemic: Simplifying While Not Compromising Care.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 14 8 2020
medline: 9 10 2020
entrez: 14 8 2020
Statut: ppublish

Résumé

Standard poststroke treatment monitoring protocols are made problematic during the coronavirus disease 2019 (COVID-19) pandemic by the frequency of patient assessments, requiring repeated donning and doffing procedures in a short interval of time. A streamlined poststroke treatment protocol was developed to limit frequency of patient encounters while maximizing the yield of each encounter by grouping together different components of poststroke care into single bedside visits. Streamlined order sets were developed late March 2020. During the first 6 weeks following implementation, 70 patients were admitted to a geographically defined designated warm COVID-19 unit with modified poststroke care order sets. Of these, 33 (47.1%) patients received acute reperfusion therapy. All but 3 patients evolved favorably with either stable or improving National Institutes of Health Stroke Scale at 24 hours. In the 3 patients who experienced early neurological deterioration, none were found to be attributable to insufficient patient monitoring. Adapting preexisting poststroke care protocols may be necessary while the risk of COVID-19 infection remains high. We propose a streamlined approach to facilitate poststroke monitoring in patients with stroke with unknown COVID status.

Sections du résumé

BACKGROUND AND PURPOSE
Standard poststroke treatment monitoring protocols are made problematic during the coronavirus disease 2019 (COVID-19) pandemic by the frequency of patient assessments, requiring repeated donning and doffing procedures in a short interval of time.
METHODS
A streamlined poststroke treatment protocol was developed to limit frequency of patient encounters while maximizing the yield of each encounter by grouping together different components of poststroke care into single bedside visits.
RESULTS
Streamlined order sets were developed late March 2020. During the first 6 weeks following implementation, 70 patients were admitted to a geographically defined designated warm COVID-19 unit with modified poststroke care order sets. Of these, 33 (47.1%) patients received acute reperfusion therapy. All but 3 patients evolved favorably with either stable or improving National Institutes of Health Stroke Scale at 24 hours. In the 3 patients who experienced early neurological deterioration, none were found to be attributable to insufficient patient monitoring.
CONCLUSIONS
Adapting preexisting poststroke care protocols may be necessary while the risk of COVID-19 infection remains high. We propose a streamlined approach to facilitate poststroke monitoring in patients with stroke with unknown COVID status.

Identifiants

pubmed: 32790493
doi: 10.1161/STROKEAHA.120.031008
pmc: PMC7446994
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3115-3118

Références

Stroke. 2017 Dec;48(12):e343-e361
pubmed: 29097489
Neurohospitalist. 2020 Jan;10(1):11-15
pubmed: 31839859
N Engl J Med. 1995 Dec 14;333(24):1581-7
pubmed: 7477192
Can J Neurol Sci. 2020 Jul;47(4):474-478
pubmed: 32654680
Stroke. 2020 Jun;51(6):1910-1912
pubmed: 32233972

Auteurs

Laura C Gioia (LC)

Department of Neurosciences, Université de Montréal (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Neurovascular Health Group, Neuroscience Axis, Centre de recherche de l'Université de Montréal (CRCHUM) (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Department of Neurology, Neurovascular Health Program, Centre hospitalier de l'Université de Montréal (CHUM). (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).

Alexandre Y Poppe (AY)

Department of Neurosciences, Université de Montréal (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Neurovascular Health Group, Neuroscience Axis, Centre de recherche de l'Université de Montréal (CRCHUM) (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Department of Neurology, Neurovascular Health Program, Centre hospitalier de l'Université de Montréal (CHUM). (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).

Roxanne Laroche (R)

Department of Nursing Sciences, Centre hospitalier de l'Université de Montréal (CHUM). (R,L., T.D.-F., I.S.).

Tristan Dacier-Falque (T)

Department of Nursing Sciences, Centre hospitalier de l'Université de Montréal (CHUM). (R,L., T.D.-F., I.S.).

Isabelle Sévigny (I)

Department of Nursing Sciences, Centre hospitalier de l'Université de Montréal (CHUM). (R,L., T.D.-F., I.S.).

Nicole Daneault (N)

Department of Neurosciences, Université de Montréal (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Neurovascular Health Group, Neuroscience Axis, Centre de recherche de l'Université de Montréal (CRCHUM) (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Department of Neurology, Neurovascular Health Program, Centre hospitalier de l'Université de Montréal (CHUM). (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).

Yan Deschaintre (Y)

Department of Neurosciences, Université de Montréal (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Neurovascular Health Group, Neuroscience Axis, Centre de recherche de l'Université de Montréal (CRCHUM) (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Department of Neurology, Neurovascular Health Program, Centre hospitalier de l'Université de Montréal (CHUM). (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).

Grégory Jacquin (G)

Department of Neurosciences, Université de Montréal (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Neurovascular Health Group, Neuroscience Axis, Centre de recherche de l'Université de Montréal (CRCHUM) (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Department of Neurology, Neurovascular Health Program, Centre hospitalier de l'Université de Montréal (CHUM). (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).

Christian Stapf (C)

Department of Neurosciences, Université de Montréal (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Neurovascular Health Group, Neuroscience Axis, Centre de recherche de l'Université de Montréal (CRCHUM) (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Department of Neurology, Neurovascular Health Program, Centre hospitalier de l'Université de Montréal (CHUM). (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).

Celine Odier (C)

Department of Neurosciences, Université de Montréal (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Neurovascular Health Group, Neuroscience Axis, Centre de recherche de l'Université de Montréal (CRCHUM) (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).
Department of Neurology, Neurovascular Health Program, Centre hospitalier de l'Université de Montréal (CHUM). (L.C.G., A.Y.P., N.D., Y.D., G.J., C.S., C.O.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH